![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 14/505 | |
C12N 15/11 | |||
C12N 15/16 | |||
C12N 5/10 | |||
C12P 21/02 | |||
A61P 7/06 |
(11) | Number of the document | 2342223 |
(13) | Kind of document | T |
(96) | European patent application number | 09816953.5 |
Date of filing the European patent application | 2009-09-25 | |
(97) | Date of publication of the European application | 2011-07-13 |
(45) | Date of publication and mention of the grant of the patent | 2017-04-26 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2009/058482 |
Date | 2009-09-25 |
(87) | Number | WO 2010/036964 |
Date | 2010-04-01 |
(30) | Number | Date | Country code |
100679 P | 2008-09-26 | US | |
100692 P | 2008-09-26 | US |
(72) |
TIAN, Feng, US
HAYS PUTNAM, Anna-Maria, A., US
SONG, Frank, US
CHU, Stephanie, US
SHEFFER, Joseph, US
BARNETT, Richard, S., US
SILADI, Marc, US
ATKINSON, Kyle, US
LEE, Darin, US
CANNING, Peter, C., US
|
(73) |
ELI LILLY AND COMPANY,
Lilly Corporate Center, Indianapolis, IN 46285,
US
Ambrx, Inc., 10975 North Torrey Pines Road, Suite 100, La Jolla, CA 92037, US |
(54) | MODIFIED ANIMAL ERYTHROPOIETIN POLYPEPTIDES AND THEIR USES |
MODIFIED ANIMAL ERYTHROPOIETIN POLYPEPTIDES AND THEIR USES |